Virtual Interaction With Experts: Exploring Novel Therapeutics in Acute Myeloid Leukemia

In this virtual program, faculty experts explore the use of investigational immunotherapeutic agents, including monoclonal antibody–based therapy, immune checkpoint inhibitors, vaccines, and adoptive cell–based therapy in treating patients with AML. Management of treatment-related toxicities will also be presented.
person default
Richard Dillon, MD
Guillermo Garcia-Manero, MD

Downloadable Slidesets

Download these slides to review expert insights on the standard of care treatments for elderly patients with AML in 2020

Guillermo Garcia-Manero, MD Released: July 16, 2020

Download these slides to review expert insights on latest developments in treatment of AML

person default Richard Dillon, MD Released: July 16, 2020
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley

Supported by an independent grant from
Helsinn Healthcare SA

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?